At 8 o’clock on a March morning last year, doctors at Northwick Park Hospital in London began injecting six healthy men with an experimental arthritis drug. It was the drug’s first safety trial in humans, and it had passed all the necessary tests on mice and monkeys with no indication of danger.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.